MARY BERNARD: Open Payments
NPI 1457344152 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 13 payments from 10 companies in 2025. Trend: 2023 $429 · 2024 $582 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $243 |
| ABBVIE INC. | 2 | $218 |
| Lilly USA, LLC | 2 | $133 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| Dexcom, Inc. | 1 | $93 |
Products named: SPRAVATO, INGREZZA, VRAYLAR, VOQUEZNA, COBENFY, Ohtuvayre, INVEGA SUSTENNA, UZEDY.
Industry payments across WA — which companies pay providers there.
